MedPath

Suppressive effects of a test food on blood glucose level

Not Applicable
Conditions
Patients receiving enteral tube feeding
Registration Number
JPRN-UMIN000053387
Lead Sponsor
Seishukai Clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1)Subjects who meet both of the following criteria in the preliminary survey. i)Fasting blood glucose level is 126 mg/dL or more. ii)HbA1c value is 6.5 % or more. 2)Subjects who have been diagnosed with diabetes. 3)Subjects taking medications that may affect blood glucose levels. 4)Subjects who are under medical treatment of diseases in liver, kidneys, heart, lungs, digestive system, blood, endocrine and metabolic systems, or who have serious medical history of those diseases. 5)Subjects who exhibit allergic symptoms due to intake of milk or soybean-derived ingredients. 6)Subjects who donated/collected blood components or 200 mL or more of blood in the past 1 month, or who donated/collected 400 mL or more of blood on the past 4 months. 7)Subjects who plan to participate in other clinical trials during the trial period. 8)Others who are judged by the investigator to be inappropriate as participants in this test.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Area under the curve of postprandial blood glucose
Secondary Outcome Measures
NameTimeMethod
Blood glucose, insulin level, blood amino acids, GLP-1 level, and GIP level
© Copyright 2025. All Rights Reserved by MedPath